“…[3,[20][21][22][23] The most studied in ammatory cytokines in AIS are the pro-in ammatory cytokines IL-1β, Il-6, and TNF-α. [9,17] In this study, we did not include TNF-α because the increasing trend of TNF-α, IL-1β, and IL-6 was consistent; for example, a previous study showed within 72 h of neurological sign onset, in a 1month follow-up period, they assessed NIHSS as primary and plasma levels of TNF-α, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IFN-γ, IP-10, MCP-1, 8-isoprostane were increased. The levels of plasma in ammatory markers TNF-α, IL-1β, IL-6, IL-8, and prostaglandin E2 P were signi cantly decreased in a therapy group after 7 days of intervention, [24] but the in ammatory factors IL-1β and IL-6 were increased signi cantly in cerebral ischemia.…”